Dominican Republic vs Morocco: Average cost of drugs for extensively drug-resistant tuberculosis
Dominican Republic
4,000 constant 2022 US$
in 2024
Morocco
4,500 constant 2022 US$
in 2024
Dominican Republic rank
17th
Morocco rank
14th
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Dominican Republic
- Morocco
How they compare
Morocco currently reports 4,500 constant 2022 US$ against 4,000 constant 2022 US$ in Dominican Republic, a difference of 500 constant 2022 US$.
That makes Morocco's figure about 1.1 times Dominican Republic's.
The two have swapped places 3 times across 7 shared years of data; in 2017 it was Dominican Republic ahead.
Dominican Republic ranks 17th and Morocco ranks 14th of 56 countries.
Across the 2 decades both report, Dominican Republic averaged higher in 1 and Morocco in 1.
Head to head by decade
| Decade | Dominican Republic | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17,073 constant 2022 US$ | 7,423 constant 2022 US$ | 9,650 constant 2022 US$ | Dominican Republic |
| 2020s | 2,022 constant 2022 US$ | 3,904 constant 2022 US$ | 1,882 constant 2022 US$ | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Dominican Republic or Morocco?
- Morocco, at 4,500 constant 2022 US$ against 4,000 constant 2022 US$ in Dominican Republic as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Dominican Republic and Morocco?
- 500 constant 2022 US$, with Morocco ahead.
- How many years of comparable data are there for Dominican Republic and Morocco?
- 7 years are reported by both, from 2017 to 2024.
- How do Dominican Republic and Morocco rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Dominican Republic ranks 17th and Morocco ranks 14th of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.